These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 385005)

  • 21. [Protein binding of the macrolide antibiotic turimycin. Methodologic effects on results].
    Hesse G; Hoffmann H; Fricke H; Fleck WF
    Pharmazie; 1983 Nov; 38(11):740-3. PubMed ID: 6669594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hummel-Dreyer method: impact in pharmacology.
    Soltés L
    Biomed Chromatogr; 2004 May; 18(4):259-71. PubMed ID: 15162389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Convalent binding of various tetra- and tricyclic heterocycles with isothiocyanate structure to human serum albumin and bovine gamma globulin. Part 24: Immunosuppressive agent - antigen conjugates (author's transl)].
    Wagner G; Bunk E
    Pharmazie; 1979 Oct; 34(10):640-5. PubMed ID: 94443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico prediction of drug-binding strengths to human serum albumin.
    Colmenarejo G
    Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-protein interaction: plasma protein binding of furocoumarins.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1979 Aug; 34(8):716-25. PubMed ID: 467637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for drug binding to site II on human serum albumin.
    Wanwimolruk S; Birkett DJ; Brooks PM
    Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Binding of sulfonamides to protein. 6. Determination of protein binding of sulfonamides by means of ultracentrifuge and gel filtration].
    Scholtan W
    Arzneimittelforschung; 1965 Dec; 15(12):1433-41. PubMed ID: 5899818
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the binding between uric acid and plasma proteins (author's transl)].
    Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C
    Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipophilicity-protein binding relationship in cardenolides (author's transl)].
    Hempelmann FW; Heinz N
    Arzneimittelforschung; 1978; 28(12):2185-7. PubMed ID: 582928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple method for prediction and estimation of the hemodialysability of incorporated drugs.
    Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):217-22. PubMed ID: 4021653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of drug-plasma protein binding using human serum albumin chromatographic column and multiple linear regression model.
    Beaudry F; Coutu M; Brown NK
    Biomed Chromatogr; 1999 Oct; 13(6):401-6. PubMed ID: 10477897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma protein binding. Review].
    von Schwarzenfeld I
    Pharmazie; 1974 Aug; 29(8):497-505. PubMed ID: 4605865
    [No Abstract]   [Full Text] [Related]  

  • 36. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs, receptors and serum protein binding.
    Kunin CM
    N Engl J Med; 1969 Nov; 281(21):1188-9. PubMed ID: 5347831
    [No Abstract]   [Full Text] [Related]  

  • 38. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
    Pacifici GM; Viani A
    Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of drug-albumin binding in buffered bovine serum albumin solutions applying a modified ultrafiltration process (author's transl)].
    Kinawi A; Teller C
    Arzneimittelforschung; 1979; 29(10):1495-500. PubMed ID: 583210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.